Page 52 - Read Online
P. 52
Page 14 of 25 Han et al. Cancer Drug Resist 2024;7:16 https://dx.doi.org/10.20517/cdr.2024.01
***
**
Figure 4. (A) The viability of U251 cells after 12 and 24 h of isocuB treatment ( P < 0.01, P < 0.001; **** P < 0.0001 vs. control group);
***
(B) The viability of U87 cells after 24 h of isocuB treatment ( P < 0.001; **** P < 0.0001 vs. control group); (C and D) Cell mobility of
***
*
**
U251 cells after12, 24 and 36 h of isocuB treatment ( P < 0.05, P < 0.01, P < 0.001 vs. control group). isocuB: Isocucurbitacin B.
